EODData

NASDAQ, TECH: Bio-Techne Corp

07 Nov 25 15:59
LAST:

57.42

CHANGE:
 0.77
OPEN:
57.76
HIGH:
58.04
ASK:
104.21
VOLUME:
844.6K
CHG(%):
1.32
PREV:
58.18
LOW:
56.53
BID:
90.24
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 2557.7658.0456.5357.411.76M
06 Nov 2560.4360.7956.9358.182.37M
05 Nov 2554.4061.1254.2059.944.3M
04 Nov 2561.2262.6760.7761.103.02M
03 Nov 2561.9162.3860.7861.261.88M
31 Oct 2560.8162.9660.4862.572.11M
30 Oct 2561.8562.2360.8160.961.42M
29 Oct 2563.5064.1061.3762.021.83M
28 Oct 2564.6565.1663.6063.941.14M
27 Oct 2565.7965.8664.1664.251.69M

COMPANY PROFILE

Name:Bio-Techne Corp
About:Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Sector:Healthcare
Industry:Biotechnology
Address:614 McKinley Place N.E., Minneapolis, MN, United States, 55413
Website:https://www.bio-techne.com
CUSIP:878377100
CIK:0000842023
ISIN:US09073M1045
FIGI:BBG000C15114
LEI:54930073RLKQ51TILZ35

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:136.02 
Forward P/E:28.57 
PEG Ratio:-0.96 
Price to Sales:7.99 
Price to Book:5.05 
Profit Margin:0.06 
Operating Margin:0.36 
Return on Assets:0.06 
Return on Equity:0.04 
EPS Ratio:0.46 
DivYield:0.01 
Div/Share:0.32 
Revenue:1.22B 
EBITDA:216.87M 
Shares:155.69M 
Market Cap:8.94B 

TECHNICAL INDICATORS

MA5:59.583.8%
MA10:61.166.5%
MA20:61.777.6%
MA50:57.630.4%
MA100:55.563.3%
MA200:56.092.4%
RSI14:33.33 
WPR14:-100.00 
MTM14:-6.05
ROC14:-0.10 
ATR:2.47 
Week High:62.969.6%
Week Low:54.205.9%
Month High:66.9616.6%
Month Low:54.202.4%
Year High:79.2838.1%
Year Low:46.0124.8%

RECENT SPLITS

Date Ratio
30 Nov 20224-1
04 Dec 20002-1
18 Nov 19972-1

RECENT DIVIDENDS

Date Amount
18 Aug 2025$0.08
19 May 2025$0.08
14 Feb 2025$0.08
08 Nov 2024$0.08
19 Aug 2024$0.08
10 May 2024$0.08
09 Feb 2024$0.08
09 Nov 2023$0.08
17 Aug 2023$0.08
12 May 2023$0.08